tiprankstipranks
Inhibitor Therapeutics Inc. (INTI)
OTHER OTC:INTI
US Market

Inhibitor Therapeutics (INTI) Income Statement

Compare
28 Followers

Inhibitor Therapeutics Income Statement

Last quarter (Q3 2024), Inhibitor Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Inhibitor Therapeutics's net income was $-730.96K. See Inhibitor Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 3.40M$ 657.93K$ 325.39K$ 1.06M$ 2.75M
Depreciation and Amortization
$ 3.40M$ 657.93K$ 325.39K$ 1.06M$ 2.75M
EBITDA
$ 378.84K$ -657.93K$ -325.39K$ -1.06M$ -2.75M
Operating Income
$ -3.40M$ -657.93K$ -325.39K$ -1.06M$ -2.75M
Other Income/Expenses
$ 378.84K$ 12.82M$ 26.76K$ 1.07K$ 14.54K
Pretax Income
$ -3.03M$ 12.16M$ -298.63K$ -1.06M$ -2.73M
Net Income
$ -3.03M$ 12.11M$ -313.47K$ -1.06M$ -2.72M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.02$ 0.03$ 0.00$ 0.00$ -0.01
Diluted EPS
$ -0.02$ 0.03$ 0.00$ 0.00$ -0.01
Weighted Average Shares Outstanding
151.31M 366.18M 376.25M 371.93M 370.43M
Weighted Average Shares Outstanding (Diluted)
171.95M 367.78M 376.25M 371.93M 370.43M
Currency in USD

Inhibitor Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis